Bayer’s $10 Billion Roundup Reckoning: Lawsuits, Public Health, and the Fight Ahead
- M.R Mishra
- Mar 23
- 2 min read
Bayer AG, the German pharmaceutical and life sciences company, has been embroiled in extensive litigation over allegations that its glyphosate-based herbicide, Roundup, causes cancer.
These legal challenges have persisted despite Bayer's acquisition of Monsanto, the original manufacturer of Roundup, in 2018.
The controversy intensified following a 2015 report by the International Agency for Research on Cancer (IARC), which classified glyphosate as "probably carcinogenic to humans."
This classification led to a surge in lawsuits against Monsanto, alleging that exposure to Roundup resulted in non-Hodgkin's lymphoma and other cancers.
In August 2018, a landmark case concluded with a San Francisco jury awarding $289 million in damages to Dewayne Johnson, a school groundskeeper who claimed his cancer was caused by Roundup.
This verdict was later reduced to $78 million on appeal. Subsequent lawsuits have yielded mixed outcomes;
for instance, in May 2019, a California jury awarded over $2 billion to a couple alleging Roundup caused their cancer, though this amount was later reduced to $87 million.
In June 2020, Bayer agreed to a settlement ranging from $8.8 to $9.6 billion to resolve existing lawsuits, with an additional $1.25 billion allocated for potential future claims.
Despite these settlements, Bayer continues to face new lawsuits and has been actively lobbying for legislative changes to mitigate future liabilities.
The scientific community remains divided on glyphosate's carcinogenicity.
While the IARC has raised concerns, other regulatory bodies, including the U.S. Environmental Protection Agency (EPA), have stated that glyphosate is "not likely to be carcinogenic to humans" when used as directed.
This dichotomy has fueled ongoing debates and legal battles, leaving consumers and professionals in the agricultural sector uncertain about the herbicide's safety.
In my opinion, the persistent legal challenges and contrasting scientific opinions surrounding glyphosate highlight the necessity for comprehensive, transparent, and independent research.
Such efforts are essential to conclusively determine the safety of glyphosate-based products and to guide regulatory policies that protect public health while considering the needs of agricultural practices.
Read Full article:
Commentaires